J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.

18:46 24/02/2025

On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.

According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.

Shanghai Fosun Pharmaceutical (02196) released its annual performance, with a net profit attributable to the parent company of 3.371 billion yuan, an increase of 21.69% year-on-year.

PER ENERGY (02798) announces annual performance results with a net loss of 1.98 billion yuan, a turnaround from profit to loss on a year-on-year basis.

LIVZON PHARMA (01513) will distribute a final dividend of HK$14.3 per 10 shares.

Shanghai Fosun Pharmaceutical (02196) released its annual performance, with a net profit attributable to the parent company of 3.371 billion yuan, an increase of 21.69% year-on-year.

PER ENERGY (02798) announces annual performance results with a net loss of 1.98 billion yuan, a turnaround from profit to loss on a year-on-year basis.

LIVZON PHARMA (01513) will distribute a final dividend of HK$14.3 per 10 shares.